Back to News
Jan 20, 2026 4:00 PM

Bristol Myers, Microsoft Aim To Catch Lung Cancer Early With New AI Tool

U.S. drug giant Bristol Myers Squibb Co (NYSE:BMY) has partnered with Microsoft Inc (NASDAQ:MSFT), aiming to accelerate early detection of lung cancer.

The goal is to deploy U.S. FDA-cleared radiology AI algorithms through Microsoft's Precision Imaging Network.

The platform, used by more than 80% of U.S. hospitals, applies AI to automatically analyze X-ray and CT scans, helping radiologists identify hard-to-detect lung nodules, flag patients earlier in the disease cycle ...